Mechanism underlying anti-apoptotic activity of a (−)deprenyl-related propargylamine, rasagiline
- 1 July 2000
- journal article
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 116 (2-3) , 181-191
- https://doi.org/10.1016/s0047-6374(00)00144-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- (−)‐Deprenyl Protects Human Dopaminergic Neuroblastoma SH‐SY5Y Cells from Apoptosis Induced by Peroxynitrite and Nitric OxideJournal of Neurochemistry, 1998
- Rapid Loss in the Mitochondrial Membrane Potential during Geranylgeranoic Acid-Induced ApoptosisBiochemical and Biophysical Research Communications, 1997
- Modulation of gene expression rather than monoamine oxidase inhibitionNeurology, 1996
- Effect of Long‐Term Treatment with Selective Monoamine Oxidase A and B Inhibitors on Dopamine Release from Rat Striatum In VivoJournal of Neurochemistry, 1996
- The effect of deprenyl and levodopa on the progression of Parkinson's diseaseAnnals of Neurology, 1995
- The advent of selective monoamine oxidase A inhibitor antidepressants devoid of the cheese reactionActa Psychiatrica Scandinavica, 1995
- (−)‐Deprenyl Reduces PC12 Cell Apoptosis by Inducing New Protein SynthesisJournal of Neurochemistry, 1994
- Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1993
- (−) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male ratsLife Sciences, 1991
- TYRAMINE ANTAGONISTIC PROPERTIES OF AGN 1135, AN IRREVERSIBLE INHIBITOR OF MONOAMINE OXIDASE TYPE BBritish Journal of Pharmacology, 1981